Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Smoke Inhalation Injury 1Respiratory Aspiration 1Lung Neoplasms 1Lung Diseases, Interstitial 1Lung Diseases 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Health Records, Personal × Thoracic × Clear all
NCT06836414 2026-04-13

Lung Cancer Screening CT for Firefighters

University of California, San Francisco

Phase NA Withdrawn
Thoracic

Lung Diseases, Lung Neoplasms, Smoke Inhalation Injury, Lung Diseases, Interstitial, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡